- 7.1 million people globally are HIV positive but don't know it, and only 59% of people living with HIV are taking medication to suppress the virus.
- The collaboration focuses on raising awareness across Africa about the importance of diagnostic testing and regular screening for HIV and how it can contribute to ending HIV and AIDS
- Roche’s Global Access Program and (RED) share a mission to improve access to HIV diagnostics with the goal of an AIDS-free generation by 2030
Pleasanton, July 15, 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it is joining forces with (RED) on a shared mission to raise awareness of the importance of diagnostic testing in the global fight against HIV/AIDS. (RED) is a division of the ONE Campaign, a global movement to end extreme poverty and preventable disease by 2030 so that everyone, everywhere can lead a life of dignity and opportunity. This is the first collaboration between (RED) and a diagnostics company.
Roche, through our Global Access Program, is committed to providing care where access is limited, and is excited to partner with (RED) in its efforts to help countries achieve the goals of UNAIDS,
said Bernard Colombo, President Europe Middle East, Africa and Latin America, Roche Diagnostics International.
Through this partnership, there is an opportunity to encourage more widespread HIV diagnostic testing so that people living with HIV are empowered to better manage and maintain their health for a prosperous future.
Since 2014, Roche’s Global Access Program has increased access to HIV diagnostics in areas most impacted and in need. Together, as a community and in partnership with (RED), raising awareness around the importance of HIV diagnostic testing for improved disease management supports Joint United Nations Programme on HIV and AIDS (UNAIDS) goals of an AIDS-free generation by 2030, which calls for zero new HIV infections, zero discrimination and zero AIDS-related deaths. Most recently, the Global Access Program included the innovative cobas® Plasma Separation Card to provide the only CE-marked plasma sample collection device which meets the World Health Organization sensitivity standards.
Jennifer Lotito, President and Chief Operating Officer, (RED), said: